2025 AustinPx Amorphous Solid Dispersion (ASD) Workshop Recap
Go inside AustinPx’s 2025 ASD Workshop, Downstream Aspects of Amorphous Solid Dispersions. The multi-day event brought together experts from industry and academia to explore patient-centric drug product design, characterization, stability, scale-up, and downstream ASD manufacturing. Hear from speakers and attendees about the science, collaboration, facility tours, and live KinetiSol™ demonstrations that made the workshop memorable.
Read MoreOutsourcedPharma Live: AustinPx Facility Tour & Capabilities Presentation
Join AustinPx’s Chief Scientific Officer, Dave Miller, for a presentation focusing on our pharmaceutical manufacturing & development capabilities. Dave’s presentation is followed by a virtual facility tour that will take you behind the scenes of our manufacturing areas by AustinPx’s Senior VP, Operations, Justin Keen.
Read MoreOverview: KinetiSol Technology from AustinPx
The KinetiSol™ Technology generates amorphous solid dispersions, dramatically improving the bioavailability of poorly soluble drugs. KinetiSol is a fusion-based, solvent-free process that utilizes frictional and shear energies – in a fraction of the time of other ASD technologies. With its significantly smaller ecological footprint, broader formulation design space, faster processing times and wider application to…
Read MoreKinetiSol in Action: Scalable, Sustainable Amorphous Dispersion Manufacturing
See the KinetiSol Compounder in action and learn how AustinPx’s proprietary KinetiSol™ Technology supports amorphous solid dispersion (ASD) development from rapid prototyping through commercial manufacturing. This video highlights how KinetiSol’s solvent-free, fusion-based process forms ASDs in seconds, simplifies scale-up, reduces operational burden, and expands the formulation design space for complex molecules. With a focus on scalability,…
Read MoreAustinPx Live: Inside AustinPx: Live Company Overview (Episode 1)
We kicked off our new AustinPx Live series with Inside AustinPx: Live Company Overview, featuring Chief Scientific Officer Dave Miller, Ph.D. In this 30-minute session, Dave walked attendees through our evolution from sponsor to CDMO, our integrated development and manufacturing capabilities, and how we apply science-backed, patient-focused strategies to solve complex formulation challenges including through our…
Read More